Physician profile
Spenser E Cammack
NPI 1457524589
$2,374.49
in general payments reported to CMS, 2019-2025
8 companies · $533 in 2025
The $533 reported for 2025 was more than what 91% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $276 · 2021: $28.41 · 2022: $13.70 · 2023: $1,508 · 2024: $14.50 · 2025: $533.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $869 · Entertainment: $500 · Consulting Fee: $400 · Education: $288.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $868.57 |
| Entertainment | $500.00 |
| Consulting Fee | $400.00 |
| Education | $287.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Sirona INC | $1,628.01 | 2020-2025 | Suresmile, Cerec, Cavitron |
| Dentsply LLC | $400.00 | 2025 | |
| Patterson Companies, INC. | $149.50 | 2020 | |
| Solventum Corporation | $111.57 | 2025 | Clarity Aligners |
| Voco America INC. | $37.84 | 2020-2024 | Grandio Blocs, Grandio So, Grandio So Heavy Flow |
| Orapharma, A Division of Bausch Health US, LLC | $16.98 | 2021 | |
| Gc America INC. | $15.65 | 2020 | |
| Nobel Biocare USA | $14.94 | 2023 | Nobelactive |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Spenser Cammack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.